18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.

[1]  J. Purdy,et al.  Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. , 1995, International journal of radiation oncology, biology, physics.

[2]  G. V. von Schulthess,et al.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.

[3]  V. Lowe,et al.  Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. , 1996, American Journal of Clinical Oncology.

[4]  T. Landberg,et al.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  R L Wahl,et al.  Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans. , 1996, Radiology.

[6]  M. Sasaki,et al.  Ringlike uptake of [18F]FDG in brain abscess: a PET study. , 1990, Journal of computer assisted tomography.

[7]  Y. Kuwabara,et al.  High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. , 1989, Journal of computer assisted tomography.

[8]  M. Graham,et al.  102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis , 1996 .

[9]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M Schwaiger,et al.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. , 1998, International journal of radiation oncology, biology, physics.

[11]  K. Nackaerts,et al.  Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer - A prospective analysis of 50 cases , 1997 .

[12]  A. Dowlati,et al.  Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. , 1996, The European respiratory journal.

[13]  Ronald J. Jaszczak,et al.  60 Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: Challenges and prospects , 1996 .

[14]  S U Berlangieri,et al.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.

[15]  S. Reske,et al.  Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). , 1997, Thorax.